Literature DB >> 16293228

Peroxynitrite-induced mitochondrial translocation of PKCalpha causes U937 cell survival.

Liana Cerioni1, Letizia Palomba, Bernhard Brüne, Orazio Cantoni.   

Abstract

Our previous work has shown that non-toxic concentrations of peroxynitrite nevertheless commit U937 cells to mitochondrial permeability-transition (MPT)-dependent necrosis that is however prevented by a parallel survival signaling pathway involving cytosolic phospholipase A2 (cPLA2)-dependent arachidonic acid release and PKCalpha activation associated with the cytosolic translocation of Bad. The present study provides evidence of an early mitochondrial translocation of PKCalpha. Inhibition of the survival signaling at the level of either cPLA2, or PKC, was invariably associated with prevention of the mitochondrial localization of PKCalpha, with the mitochondrial translocation of Bad and Bax and with a very rapid lethal response. Collectively, the results presented in this study demonstrate that peroxynitrite, while committing U937 cells to necrosis, triggers a parallel signaling response leading to the cytosolic localization of two important members of the Bcl-2 family implicated in the onset of MPT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293228     DOI: 10.1016/j.bbrc.2005.10.193

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?

Authors:  Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

2.  Protein kinase C-α activation promotes recovery of mitochondrial function and cell survival following oxidant injury in renal cells.

Authors:  Grazyna Nowak; Diana Bakajsova
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-06

Review 3.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.